Le Lézard
Classified in: Health
Subjects: PDT, EGV, DIS, DEI

ClearMask introduces world's first CE-marked, fully transparent surgical mask


Fully transparent, anti-fog masks available in the European Union to provide clear communication and safety for healthcare providers and essential workers

BALTIMORE, Sept. 29, 2021 /PRNewswire/ -- ClearMask LLC, a privately held American medical supply company, announced today that its ClearMasktm is the world's first and only fully transparent surgical mask that is both CE-marked and FDA-cleared. To date, no other transparent masks meet both certifications.

The ClearMasktm: world's first CE-marked, fully transparent surgical mask

The ClearMasktm transparent surgical masks meet the CE Marking requirements as a Class I medical device under the European Union Medical Device Regulation (2017/745) and can be used in hospitals, clinics, schools, and other settings. The mask is optimized for maximum clarity and comfort, meeting applicable EN 14683 requirements for fluid resistance, microbial cleanliness, and biocompatibility, which offers a high level of protection for medical use in environments such as operating rooms.

In the United States, the ClearMasktm brand received FDA clearance as a Class II medical device on April 6, 2020, and meets applicable ASTM Level 3 requirements in the United States for fluid resistance and flammability. The ClearMasktm transparent surgical mask also passed additional tests in accordance with the transparent mask guidelines released by the United Kingdom, including tests for resistance to penetration of microorganisms (ASTM F1671) and visibility (EN 166).

During the pandemic, the ClearMasktm brand has helped provide protection against the transfer of aerosols, fluids, and sprays, and has been widely adopted as the new standard to help improve communication and trust where masks are required. With its fully transparent, anti-fog plastic barrier, the ClearMasktm brand increases visual communication, which may help avoid costly errors and adverse outcomes. As demonstrated in a first-of-its-kind study in the Journal of the American Medical Association, the ClearMasktm is also critical in establishing rapport and earning trust.

The company started developing the transparent mask in 2017 after their deaf co-founder suffered an adverse experience during her surgery. Traditional surgical masks blocked her providers' faces, impeding effective communication and essential safety checks.

"When the pandemic began, our mission was to bring a human-centered mask to everyone who needed it, especially children, older adults, deaf and hard of hearing people, and those who heavily depend on visual communication. ClearMask continues to fight against the current pandemic and we are here to stay," said Allysa Dittmar, President of ClearMask. 

To date, the company has provided over 18 million masks in the United States and globally. The company has partnered with several distributors, including Cardinal Health, Grainger, Henry Schein, McKesson, and Oaktree Products, and is currently onboarding distributors for the CE-marked masks. The masks can be purchased in the United States through ClearMask's website at www.buy.theclearmask.com, and countries outside the United States may purchase the masks here.

About ClearMask ClearMask, LLC is an American-based medical supply company that focuses on improving communication while making connections more human. Its products may help reduce errors and increase satisfaction by facilitating visual communication for all. For more information, please visit www.theclearmask.com.

Media Contact:

ClearMask, LLC
E-mail: [email protected]
Download Logo 
Download Photo 

Available Languages

Arabic 
Chinese 
French 
German 
Italian 
Japanese 
Korean 
Portuguese 
Spanish 
Thai 

Photo - https://mma.prnewswire.com/media/1637787/EZ_Adjuster_ClearMask_transparent_mask__FDA_approved.jpg


These press releases may also interest you

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 07:00
Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on TERLIVAZ® (terlipressin) for injection in patients with hepatorenal syndrome (HRS) with rapid reduction in kidney function1 at the 2024...

17 mai 2024
Family Braces, Calgary's largest group of orthodontists with five locations across the city, reports a strong start to the second quarter of 2024. This positive momentum builds on the group's successful first quarter, underlining its...

17 mai 2024
American Skin Association (ASA) announced the recipients of the 2024 Inaugural Founders Award and the 2024 Research Achievement Awards at the 2024 Society for Investigative Dermatology (SID) Annual Meeting. ...

17 mai 2024
The Honourable Seamus O'Regan Jr., Minister of Labour and Seniors, on behalf of the Honourable Mark Holland, Canada's Minister of Health, and the Honourable Tom Osborne, Newfoundland and Labrador's Minister of Health and Community Services will make...



News published on and distributed by: